Company Description

Vaxil BioTherapeutics is a clinical stage company developing a new class of synthetic therapeutic and preventive vaccines.

Vaxil BioTherapeutics Ltd. (TASE:VAXL), is a clinical stage company developing a new class of synthetic therapeutic and preventive vaccines with promiscuous antigen specific T and B-cell activation, based on its proprietary VaxHit technology.